Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Perez, Samara ^a,b   Tatar, Ovidiu ^b   Shapiro, Gilla K ^a,b   Dubé, Eve ^c   Ogilvie, Gina ^d   Guichon, Juliet ^e   Gilca, Vladimir ^c   Rosberger, Zeev ^a,b,f  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Attitudes; Beliefs; Boys; Cancer prevention; Determinants of health; Health behavior, Precaution Adoption Process Model; Health decision making; Human papillomavirus; Knowledge; Parents; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ATTITUDE TO HEALTH; CANADA; CHILD; DECISION MAKING; HUMAN; LONGITUDINAL STUDY; MALE; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PARENT; PSYCHOLOGY;

ADOLESCENT; CANADA; CHILD; DECISION MAKING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LONGITUDINAL STUDIES; MALE; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS;

EID: 85002252472     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3828-9     Document Type: Article

References (81)

1. Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;46(4 Suppl):S20-6. doi: 10.1016/j.jadohealth.2010.01.016.
2. Public Health Agency of Canada. Update On Human Papillomavirus (HPV) Vaccines [Internet]. 2012 [cited 2016 May 5]. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-1/index-eng.php. Accessed 11 Nov 2016.
3. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055.
4. Vardas E, Giuliano AR, Goldstone S, Palefsky JM, Moreira Jr ED, Penny ME, et al. External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis. 2011;203(1):58-65. doi: 10.1093/infdis/jiq015.
5. Stillo M, Carrillo Santisteve P, Lopalco PL. Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf. 2015;14(5):697-712. doi: 10.1517/14740338.2015.1013532.
6. Ogilvie GS, Naus M, Money DM, Dobson SR, Miller D, Krajden M, et al. Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis. Int J Cancer. 2015;137(8):1931-7. doi: 10.1002/ijc.29508.
7. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85(7):499-502. doi: 10.1136/sti.2009.037788.
8. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377(9783):2085-92. doi: 10.1016/S0140-6736(11)60551-5.
9. Howell-Jones R, Soldan K, Wetten S, Mesher D, Williams T, Gill ON, et al. Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study. J Infect Dis. 2013;208(9):1397-403. doi: 10.1093/infdis/jit361.
10. Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Br Med J. 2013;346:f2032. doi: 10.1136/bmj.f2032.
11. Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis. 2013;208(3):385-93. doi: 10.1093/infdis/jit192.
12. Garland SM, Kjaer SK, Munoz N, Block SL, Brown DR, DiNubile MJ, et al. Impact and Effectiveness Of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of Ten Years of Real-World Experience. Clin Infect Dis. 2016. doi: 10.1093/cid/ciw354
13. Public Health Agency of Canada, Dawar M, Dobson S, Deeks S. Literature review on HPV 6, 11, 16 and 18: Disease and Vaccine Characteristics [Internet]. 2007 [cited 2016 January 20]. Available from: http://www.phac-aspc.gc.ca/naci-ccni/pdf/lr-sl-2-e.pdf. Accessed 11 Nov 2016.
14. Shapiro GK, Perez S, Rosberger Z. Including males in Canadian human papillomavirus vaccination programs: a policy analysis. CMAJ. 2016. doi: 10.1503/cmaj.150451
15. Burchett HE, Mounier-Jack S, Griffiths UK, Mills AJ. National decision-making on adopting new vaccines: a systematic review. Health Policy Plan. 2012;27 Suppl 2:ii62-76. doi: 10.1093/heapol/czr049.
16. Zimet GD, Rosenthal SL. HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010;117(2 Suppl):S26-31. doi: 10.1016/j.ygyno.2010.01.028.
17. Olsen J, Jorgensen TR. Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females. Cost Eff Resour Alloc. 2015;13:4. doi: 10.1186/s12962-015-0029-9.
18. Pearson AL, Kvizhinadze G, Wilson N, Smith M, Canfell K, Blakely T. Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program. BMC Infect Dis. 2014;14:351. doi: 10.1186/1471-2334-14-351.
19. Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, et al. A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer. 2015;121(11):1785-92. doi: 10.1002/cncr.29111.
20. Stanley M. HPV vaccination in boys and men. Hum Vaccin Immunother. 2014;10(7):2109-11. doi: 10.4161/hv.29137.
21. Shapiro G, Guichon J, Perez S, Rosberger Z. British Columbia's flawed HPV vaccination policy [Internet]. Policy Options; 2015 [updated September 25, 2015; cited 2016 May 5]. Available from: http://policyoptions.irpp.org/issues/september-2015/british-columbias-flawed-hpv-vaccination-policy/.
22. Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis. 2011;204(3):372-6. doi: 10.1093/infdis/jir285.
23. Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report - Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males - Advisory Commitee on Immunization (ACIP), 2011. [Internet]. [updated December 23, 2011; cited 2016 November 11]. Available from: http://www.cdc.gov/mmwr/pdf/wk/mm6050.pdf. Accessed 11 Nov 2016.
24. Australian Government Department of Health. Immunise Australia Program-Human Papillomavirus (HPV) [Internet]. 2015 [updated April 20, 2015; cited 2016 January 20]. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv. Accessed 11 Nov 2016.
25. European Center For Disease Prevention and Control. ECDC GUIDANCE Introduction of HPV vaccines in European Union countries - an update. 2012.
26. Prue G. Human papillomavirus: a strong case for vaccinating boys. Trends Urology Men's Health. 2016;7(1):7-11. doi: 10.1002/tre.499/pdf.
27. News BG. HPV immunization program expanded to vulnerable boys [Internet]. 2015 [updated July 7, 2015; cited 2016 May 30]. Available from: https://news.gov.bc.ca/stories/hpv-immunization-program-expanded-to-vulnerable-boys. Accessed 11 Nov 2016.
28. Ministry of Health and Long-Term Care Ontario. Expanding Ontario's Immunization Program to Help Protect Against Cancer [Internet]. 2016 [updated April 21, 2016; cited 2016 May 5]. Available from: https://news.ontario.ca/mohltc/en/2016/4/ontario-expanding-hpv-vaccine-program-to-include-boys.html. Accessed 11 Nov 2016.
29. Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546-56. doi: 10.1016/j.vaccine.2012.03.063.
30. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine. 2006;24 Suppl 3:S3/201-9. doi: 10.1016/j.vaccine.2006.06.017.
31. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013.
32. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008;46(2):87-98. doi: 10.1016/j.ypmed.2007.09.003.
33. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010;28(24):4027-37. doi: 10.1016/j.vaccine.2010.03.063.
34. Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2010;35(7):704-15. doi: 10.1093/jpepsy/jsp108.
35. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010;46(2):113-23. doi: 10.1016/j.jadohealth.2009.11.199.
36. Bartlett JA, Peterson JA. The uptake of Human Papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011;27(6):434-46. doi: 10.1177/1059840511415861.
37. Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int. 2012;2012:1-12. doi: 10.1155/2012/921236.
38. Gainforth HL, Cao W, Latimer-Cheung AE. Determinants of human papillomavirus (HPV) vaccination intent among three Canadian target groups. J Cancer Educ. 2012;27(4):717-24. doi: 10.1007/s13187-012-0389-1.
39. Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak K, et al. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sex Transm Infect. 2008;84(4):318-23. doi: 10.1136/sti.2007.029389.
40. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2187-98. doi: 10.1158/1055-9965.EPI-10-0217.
41. Garcini LM, Galvan T, Barnack-Tavlaris JL. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine. 2012;30(31):4588-95. doi: 10.1016/j.vaccine.2012.04.096.
42. Cunningham MS, Davison C, Aronson KJ. HPV vaccine acceptability in Africa: a systematic review. Prev Med. 2014;69:274-9. doi: 10.1016/j.ypmed.2014.08.035.
43. Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer BK, Viswanath K, editors. Health Behavior and Health Education: Theory, Research and Practice. 4th ed. San Francisco, CA: Jossey-Bass; 2008. p. 45-62.
44. Weinstein ND, Sandman PM, Blalock SJ. The Precaution Adoption Process Model. San Francisco: Jossey-Bass; 2008.
45. Court of Appeal of Alberta. J.S.C. v. Wren, 1986 ABCA 249 [Internet]. 1986 [updated December 31, 1986; cited 2016 May 11]. Available from: http://www.canlii.org/en/ab/abca/doc/1986/1986abca249/1986abca249.html. Accessed 11 Nov 2016.
46. Judgements of the Supreme Court of Canada. A.C. v. Manitoba (Director of Child and Family Services), 2009 SCC 30, [2009] 2 S.C.R. 181 [Internet]. 2009 [updated June 26, 2009; cited 2016 May, 11]. Available from: https://scc-csc.lexum.com/scc-csc/scc-csc/en/item/7795/index.do. Accessed 11 Nov 2016.
47. Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knauper B, et al. Human papillomavirus vaccination intentions and uptake in college women. Health Psychol. 2012;31(5):685-93. doi: 10.1037/a0027012.
48. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. Plos Med. 2010;7(5):e1000270. doi: 10.1371/journal.pmed.1000270.
49. Richman AR, Coronado GD, Arnold LD, Fernandez ME, Glenn BA, Allen JD, et al. Cognitive testing of human papillomavirus vaccine survey items for parents of adolescent girls. J Low Genit Tract Dis. 2012;16(1):16-23. doi: 10.1097/LGT.0b013e3182293a49.
50. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108-15. doi: 10.1016/j.jadohealth.2006.10.007.
51. Krieger JL, Kam JA, Katz ML, Roberto AJ. Does mother know best? an actor-partner model of college-age women's human papillomavirus vaccination behavior. Hum Commun Res. 2011;37(1):107-24. doi: 10.1111/j.1468-2958.2010.01395.x.
52. Wong CA, Berkowitz Z, Dorell CG, Anhang Price R, Lee J, Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer. 2011;117(24):5612-20. doi: 10.1002/cncr.26246.
53. Jacob C. Statistical Power Analysis for the Behavioral Sciences. Secondth ed. New York: Lawrence Erlbaum Associates; 2008.
54. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45(5):528-31. doi: 10.1016/j.jadohealth.2009.02.006.
55. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204. doi: 10.1097/OLQ.0b013e3181f12dbf.
56. Waller J, Ostini R, Marlow LA, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013;56(1):35-40. doi: 10.1016/j.ypmed.2012.10.028.
57. Chow SN, Soon R, Park JS, Pancharoen C, Qiao YL, Basu P, et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine. 2010;28(22):3809-17. doi: 10.1016/j.vaccine.2010.03.027.
58. Montano DE, Kasprzyk D. Theory of Reasoned Action, Theory of Planned Behavior, and the Integrated Behavioral Model. In: Glanz K, Rimer B, Viswanath K, editors. Health Behavior: Theory, Research, and Practice. San Francisco, CA, USA: 5 ed: Jossey-Bass; 2015. p. 95-124.
59. Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Research. 2016;2:167-172. doi: 10.1016/j.pvr.2016.09.001.
60. Bruder M, Haffke P, Neave N, Nouripanah N, Imhoff R. Measuring individual differences in generic beliefs in conspiracy theories across cultures: conspiracy mentality questionnaire. Front Psychol. 2013;4:225. doi: 10.3389/fpsyg.2013.00225.
61. Meade AW, Craig SB. Identifying careless responses in survey data. Psychol Methods. 2012;17(3):437-55. doi: 10.1037/a0028085.
62. Weinberger DA. Construct Validation of the Weinberger Adjustment Inventory. 1987. Unpublished work.
63. Johnson JA. Ascertaining the validity of individual protocols from Web-based personality inventories. J Res Pers. 2005;39(1):103-29. doi: 10.1016/j.jrp.2004.09.009.
64. Kurtz JE, Parrish CL. Semantic response consistency and protocol validity in structured personality assessment: the case of the NEO-PI-R. J Pers Assess. 2001;76(2):315-32. doi: 10.1207/S15327752JPA7602-12.
65. Stupiansky NW, Zimet GD, Cummings T, Fortenberry JD, Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health. 2012;50(1):103-5. doi: 10.1016/j.jadohealth.2011.04.010.
66. Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31(12):1560-8. doi: 10.1016/j.vaccine.2012.10.089.
67. Perez S, Tatar O, Ostini R, Shapiro GK, Waller J, Zimet G, et al. Extending and validating a human papillomavirus (HPV) knowledge measure in a national sample of Canadian parents of boys. Prev Med. 2016;91:43-9. doi: 10.1016/j.ypmed.2016.07.017.
68. Perez S, Shapiro GK, Tatar O, Joyal-Desmarais K, Rosberger Z. Development and validation of the human papillomavirus attitudes and beliefs scale in a National Canadian sample. Sex Transm Dis. 2016;43(10):626-32. doi: 10.1097/olq.0000000000000506.
69. Gilbert NL, Gilmour H, Dube E, Wilson SE, Laroche J. Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey. Hum Vaccin Immunother. 2013;2016:1-7. doi: 10.1080/21645515.2016.1153207.
70. Gollwitzer PM. Implementation intentions: strong effects of simple plans. Am Psychol. 1999;54(7):493.
71. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32(19):2150-9. doi: 10.1016/j.vaccine.2014.01.081.
72. Perez S, Shapiro GK, Brown CA, Dube E, Ogilvie G, Rosberger Z. 'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons. Psychooncology. 2015;24(10):1316-23. doi: 10.1002/pon.3894.
73. Bianco A, Pileggi C, Iozzo F, Nobile CG, Pavia M. Vaccination against human papilloma virus infection in male adolescents: knowledge, attitudes, and acceptability among parents in Italy. Hum Vaccin Immunother. 2014;10(9):2536-42. doi: 10.4161/21645515.2014.969614.
74. Donahue KL, Stupiansky NW, Alexander AB, Zimet GD. Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine. 2014;32(31):3883-5. doi: 10.1016/j.vaccine.2014.05.035.
75. Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine. 2012;30(41):5928-34. doi: 10.1016/j.vaccine.2012.07.045.
76. Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103(8):1419-27. doi: 10.2105/AJPH.2012.301189.
77. Griebeler M, Feferman H, Gupta V, Patel D. Parental beliefs and knowledge about male human papillomavirus vaccination in the US: a survey of a pediatric clinic population. Int J Adolesc Med Health. 2012;24(4):315-20. doi: 10.1515/ijamh.2012.045.
78. Perkins RB, Apte G, Marquez C, Porter C, Belizaire M, Clark JA, et al. Factors affecting human papillomavirus vaccine use among White, Black and Latino parents of sons. Pediatr Infect Dis J. 2013;32(1):e38-44. doi: 10.1097/INF.0b013e31826f53e3.
79. Taylor JL, Zimet GD, Donahue KL, Alexander AB, Shew ML, Stupiansky NW. Vaccinating sons against HPV: results from a U.S. national survey of parents. PLoS ONE. 2014;9(12):e115154. doi: 10.1371/journal.pone.0115154.
80. Mortensen GL, Adam M, Idtaleb L. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey. BMC Public Health. 2015;15:624. doi: 10.1186/s12889-015-1863-6.
81. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011;29(34):5595-602. doi: 10.1016/j.vaccine.2011.06.020.